Vadhera Rakesh B, Simon Michelle
Department of Anesthesiology, University of Texas Medical Branch, Galveston, Texas.
Clin Obstet Gynecol. 2014 Dec;57(4):797-805. doi: 10.1097/GRF.0000000000000063.
Hypertensive disorders of pregnancy complicate 7% to 10% of pregnancies and are among the major causes of maternal and perinatal morbidity and mortality. Recently American College of Obstetricians and Gynecologists Taskforce on Hypertension during Pregnancy modified the diagnosis and management of hypertension in pregnancy, recommending prompt diagnosis, admission, close monitoring, and treatment. They strive to decrease maternal mortality and systemic complications. Labetalol, hydralazine, or nifedipine are considered first-line treatment, and either can be used to stabilize the patient with similar outcomes. Definite treatment is delivery of the fetus and should be considered based on the etiology of the hypertensive crisis and gestational age.
妊娠期高血压疾病使7%至10%的妊娠复杂化,是孕产妇和围产期发病及死亡的主要原因之一。最近,美国妇产科医师学会妊娠高血压特别工作组修改了妊娠期高血压的诊断和管理方法,建议进行快速诊断、入院、密切监测和治疗。他们致力于降低孕产妇死亡率和全身并发症。拉贝洛尔、肼屈嗪或硝苯地平被视为一线治疗药物,使用其中任何一种都可使患者病情稳定,且效果相似。确切的治疗方法是分娩胎儿,应根据高血压危机的病因和孕周来考虑。